OncoTherapy to Begin Clinical Trials of Tumor Drug in France

OncoTherapy Science Inc. (4564), a Japanese biopharmaceutical company, will begin clinical trials for a tumor drug in France, according to a statement to the Tokyo Stock Exchange today.

To contact the reporter on this story: Go Onomitsu in Tokyo at gonomitsu@bloomberg.net

To contact the editor responsible for this story: Takehiko Kumakura at tkumakura@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.